Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #295
- Final score
- 58.02
- Years on list
- 6
↘ Down 133 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 133 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 345 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 553 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | AMGN | ZTS | ELAN |
|---|---|---|---|
| Climate Change | 64.4 | 56.7 | 60.6 |
| Employee Relations | 47.2 | 70.6 | 48.3 |
| Environment | 64.0 | 59.0 | 61.6 |
| Stakeholders & Society | 66.7 | 50.9 | 63.9 |
| Human Rights | 37.4 | 47.9 | 65.2 |
| Governance | 60.9 | 64.9 | 49.9 |
| Performance Rating | 68.3 | 48.4 | 43.2 |